Tuesday, October 13, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 22, 2026

Walmart CFO Warns Higher Prices Could Hit Shelves In Coming Months

View original at finance.yahoo.com
Walmart CFO Warns Higher Prices Could Hit Shelves In Coming Months Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Q1 FY2027 revenue increased 7.3% year over year, or 5.9% in constant currency, to $177.8 billion, ahead of consensus estimates of $175.0 billion

    60% confidence
  • Sam's Club comparable sales increased 3.9%, excluding fuel

    60% confidence
  • Adjusted operating income rose 5.7% from a year earlier

    60% confidence
  • Comparable sales increased 4.1% at Walmart U.S., excluding fuel

    60% confidence
  • Global advertising revenue climbed 37% year over year, including a 36% increase in Walmart U.S. advertising sales; membership fee revenue rose 17.4% globally

    60% confidence
  • Sam's Club U.S. revenue increased 6.1% to $23.4 billion, helped by strength in grocery and general merchandise categories

    60% confidence
  • Adjusted earnings came in at 66 cents per share, matching analyst estimates

    60% confidence
  • FY2027 revenue guidance of $731.1 billion to $738.2 billion, below Wall Street forecast of $742.6 billion

    60% confidence
  • Walmart U.S. revenue growth faced a roughly 100-basis-point headwind tied to pharmacy pricing changes

    60% confidence
  • Operating cash flow totaled $4.7 billion during the quarter, while free cash flow was negative $1.9 billion

    60% confidence
  • Walmart U.S. e-commerce sales climbed 26%, fueled by 45% increase in store-fulfilled delivery, 36% rise in advertising revenue, and roughly 50% growth in Marketplace sales — strongest performance in 10 quarters

    60% confidence
  • FY2027 full-year adjusted EPS guidance of $2.75–$2.85, below Wall Street forecast of $2.94

    60% confidence
  • Higher prices could hit shelves in coming months

    60% confidence
  • Q2 FY2027 revenue projected at $182.8 billion to $184.6 billion, trailing consensus estimates of $186.4 billion

    60% confidence
  • International sales rose 10.1% to $32.8 billion, supported by continued momentum in e-commerce and store traffic

    60% confidence
  • Q2 FY2027 adjusted EPS forecast of $0.72–$0.74, below analyst expectations of $0.75

    60% confidence
  • Gross margin expanded by 6 basis points, driven primarily by strength in the U.S. business

    60% confidence

Data points we hold from this source

Walmart Inc. · international revenue32.8 USD
Walmart Inc. · operating cash flow4.7 USD
Walmart Inc. · free cash flow-1.9 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,372 source documents archived
Query this data → isubstrate.com
Walmart CFO Warns Higher Prices Could Hit Shelves In Coming Months — Source | Via News | Via News